NIPER Hyderabad develops compound targeting breast cancer cells

Researchers at NIPER Hyderabad have discovered a novel compound, VK-SN-04-419, that effectively suppresses the growth, migration, and survival of triple-negative breast cancer cells. The drug targets exosomes, thereby disrupting intercellular communication networks and halting tumour progression.